Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 5 580 JPY 6.69% Market Closed
Market Cap: 160.7B JPY
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Torii Pharmaceutical Co Ltd

Wall Street analysts forecast Torii Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Torii Pharmaceutical Co Ltd is 4 778.7 JPY with a low forecast of 4 242 JPY and a high forecast of 5 428.5 JPY.

Lowest Forecast
Wall Street Target
4 242 JPY
24% Downside
Average Forecast
Wall Street Target
4 778.7 JPY
14% Downside
Highest Forecast
Wall Street Target
5 428.5 JPY
3% Downside
Lowest
Price Target
4 242 JPY
24% Downside
Average
Price Target
4 778.7 JPY
14% Downside
Highest
Price Target
5 428.5 JPY
3% Downside
Torii Pharmaceutical Co Ltd Competitors:
Price Targets
4530
Hisamitsu Pharmaceutical Co Inc
13% Upside
P
PPLPHARMA
Piramal Pharma Ltd
43% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
9% Upside
Z
600267
Zhejiang Hisun Pharmaceutical Co Ltd
23% Downside
4530
Hisamitsu Pharmaceutical Co Inc
13% Upside
P
PPLPHARMA
Piramal Pharma Ltd
43% Upside
T
TORNTPHARM
Torrent Pharmaceuticals Ltd
9% Upside
Z
600267
Zhejiang Hisun Pharmaceutical Co Ltd
23% Downside
JNJ
Johnson & Johnson
11% Upside
234080
JW Life Science Corp
41% Upside
ANCR
Animalcare Group PLC
40% Upside

Revenue
Forecast

Revenue Estimate
Torii Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Torii Pharmaceutical Co Ltd's revenue is 0%. The projected CAGR for the next 3 years is 10%.

0%
Past Growth
10%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Torii Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Torii Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Torii Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Torii Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 17%.

7%
Past Growth
17%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Torii Pharmaceutical Co Ltd's stock price target?
Price Target
4 778.7 JPY

According to Wall Street analysts, the average 1-year price target for Torii Pharmaceutical Co Ltd is 4 778.7 JPY with a low forecast of 4 242 JPY and a high forecast of 5 428.5 JPY.

What is Torii Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Torii Pharmaceutical Co Ltd's revenue is 0%. The projected CAGR for the next 3 years is 10%.

What is Torii Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Torii Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 253,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.